Expert Opinion On Drug Metabolism & Toxicology For Peer Review Only Please download and read the Referee Guidelines Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies Journal: Expert Opinion On Drug Metabolism and Toxicology Manuscript ID EOMT-2016-0106.R1 Manuscript Type: Review IVIg, CIDP, GBS, anti-idiotype antibodies, anti-ganglioside antibodies, Keywords: sialylation, IgG molecule., Fc receptors URL: http://mc.manuscriptcentral.com/eomt Email:
[email protected] Page 1 of 60 Expert Opinion On Drug Metabolism & Toxicology 1 2 Abstract 3 4 Introduction: Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of 5 6 autoimmune and systemic inflammatory diseases with both licensed and off-label indications. The 7 mechanism of action is complex and not fully understood, involving the neutralization of 8 9 pathological antibodies, Fc receptor blockade, complement inhibition, immunoregulation of 10 11 dendritic cells, B cells and T cells and the modulation of apoptosis. 12 13 14 Areas covered:For First, this Peerreview describes Review the pharmacological propertiesOnly of IVIg, including the 15 16 composition, mechanism of action, and adverse events. The second part gives an overview of some 17 of the immune-mediated polyneuropathies, with special focus on the pathomechanism and clinical 18 19 trials assessing the efficacy of IVIg. A literature search on PubMed was performed using the terms 20 21 IVIg, IVIg preparations, side effects, mechanism of action, clinical trials, GBS, CIDP. 22 23 24 Expert opinion: Challenges associated with IVIg therapy and the treatment possibilities for 25 26 immune-mediated polyneuropathies are discussed. The availability of IVIg is limited, the expenses 27 are high, and, in several diseases, a chronic therapy is necessary to maintain the immunomodulatory 28 29 effect.